Key highlights
- Zenakine is a biotech-based neuroactive ingredient developed by Croda and SkinBiotherapeutics.
- It was introduced at in-cosmetics Global, the largest cosmetics ingredients exhibition.
- Zenakine enhances melatonin production to improve sleep quality and combat stress ageing.
- It is fully biodegradable and compliant with COSMOS and RSPO standards.
Introduction
On 8 September 2025, Croda International Plc launched Zenakine™, a biotech-based neuroactive ingredient aimed at reducing the effects of stress on the skin.
Development and Launch
Zenakine is based on research by the translational dermatology team at the University of Manchester and was developed by SkinBiotherapeutics plc. It was first introduced at in-cosmetics Global, the largest cosmetics ingredients exhibition.
Functionality
This ingredient works in sync with the skin's natural biological rhythms, enhancing melatonin production to improve sleep quality, combat stress ageing, and support overall wellbeing.
Sustainability
Zenakine is fully biodegradable and meets COSMOS and RSPO standards, reflecting Croda's commitment to environmental stewardship.
